Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis Patients

  • The PLOS ONE Staff
  • Article
  • Metrics
  • Comments
  • Media Coverage

Notice of Republication

This article was republished on February 12, 2015, to replace Figure 1, which was an erroneous duplication of Figure 2. The publisher apologizes for the error. Please download this article again to view the correct version. The originally published, uncorrected article and the republished, corrected article are provided here for reference.

Supporting Information

S1 File. Originally published, uncorrected article.

https://doi.org/10.1371/journal.pone.0120947.s001

(PDF)

S2 File. Republished, corrected article.

https://doi.org/10.1371/journal.pone.0120947.s002

(PDF)

Reference

  1. 1. Kordas G, Lagoumintzis G, Sideris S, Poulas K, Tzartos SJ (2014) Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis Patients. PLoS ONE 9(9): e108327. pmid:25259739

Citation: The PLOS ONE Staff (2015) Correction: Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis Patients. PLoS ONE 10(3): e0120947. https://doi.org/10.1371/journal.pone.0120947

Published: March 25, 2015

Copyright: © 2015 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited